Background: An increasing volume of prostate biopsies and a world-wide shortage of uro-
Introduction
Histopathological evaluation of prostate biopsies is critical to the clinical management of men suspected of having prostate cancer. Despite this importance, the histopathological diagnosis of prostate cancer is associated with several challenges:
• More than one million men undergo prostate biopsy in the United States annually. 1 With the standard biopsy procedure resulting in 10-12 needle cores per patient, this means that more than 10 million tissue samples need to be examined by pathologists. The increasing incidence of prostate cancer in an aging population means that the number of biopsies is likely to further increase.
• It is recognized that there is a shortage of pathologists internationally. In China, there is only one pathologist per 130,000 population, while in many African countries the ratio is of the order of one per million. 2, 3 Western countries are facing similar problems, with an expected decline in the number of practicing pathologists due to retirement. 4 • Gleason grade is the most important prognostic factor for prostate cancer and is crucial for treatment decisions. Gleason grade is based on morphologic examination and is recognized to be notoriously subjective. This is reflected in high intra-and inter-pathologist variability in reported grades, as well as both under-and overdiagnosis of prostate cancer. 5, 6 A possible solution to these challenges is the application of artificial intelligence (AI) to prostate cancer histopathology. The development of an AI to identify benign biopsies with high accuracy would decrease the workload of pathologists and allow them to focus on difficult cases. Further, an accurate AI could assist the pathologist with the identification, localization and grading of prostate cancer among those biopsies not culled in the initial screening process, thus providing a safety net to protect against potential misclassification of biopsies. AI-assisted pathology assessment could harmonize grading and reduce interobserver variability, leading to more consistent and reliable diagnoses and better treatment decisions.
Using high resolution scanning, tissue samples can be digitized to whole slide images (WSI) and utilized as input for the training of deep neural networks (DNN), an AI technique which has been successful in many fields, including medical imaging. [7] [8] [9] [10] Despite the many successes of AI, little work has been undertaken in prostate diagnostic histopathology. [11] [12] [13] [14] [15] [16] Attempts at grading prostate biopsies by DNNs have been limited to small datasets or subsets of Gleason patterns, and they have lacked analyses of the clinical implications of the introduction of AI-assisted prostate pathology.
In this study, we aimed to develop an AI with clinically acceptable accuracy for prostate cancer detection, localization, and Gleason grading. To achieve this, we digitized 8,313
samples from 1,222 men included in the prospective and population based STHLM3
prostate cancer diagnostic study undertaken in 2012-2015. 17 , 18 We (Table 1) . Urologists who participated in the study and the study pathologist were blinded to the clinical characteristics of the patients. A single pathologist (L.E.) graded all biopsy cores according to the ISUP grading classification (where Gleason scores 6, 3+4=7, 4+3=7, 8, and 9-10 are reported as ISUP grade 1 to 5, also referred to as Gleason Grade Groups) and delineated cancerous areas using a marker pen.
20,21
The biopsy cores were formalin fixed and stained with hematoxylin and eosin. A selection of 8,313 biopsies from 1,222 STHLM3 participants was digitized. The cases were chosen to represent the full range of diagnoses, with an over-representation of high-grade disease. We used images from 1,631 cores from a random selection of 246 (20%) men to evaluate the performance of the AI, while the rest were used for model training. That is, all biopsies from a given man were assigned to either the training or the test dataset. 22 In addition, to further enrich the data, 152 slides from men with prostate cancers of the highest grades (ISUP 4 and 5) were collected from Capio S:t Göran Hospital, Stockholm. These slides were regraded by L.E. and utilized for training purposes only. As an additional test set, we digitized 87 cores from the Pathology Imagebase, a reference database launched by ISUP. 19 Test images, as well as all cores from Imagebase patients, were not part of model development and were excluded from any analysis until the final evaluation. For details concerning data collection, see Appendix.
Artificial intelligence framework
Image pre-processing
We processed the WSIs with a segmentation algorithm based on Laplacian filtering to identify the regions corresponding to tissue sections and annotations drawn adjacent to the tissue ( Figure S1 ). We then extracted digital pixel-wise annotations, indicating the locations of cancerous tissue of any grade, by identifying the tissue region corresponding to each annotation. To obtain training data representing the morphological characteristics of Gleason patterns 3, 4 and 5, we extracted numerous partially overlapping smaller images, or patches, from each WSI. Each patch was small enough to largely represent only benign or cancerous tissue. We used patch dimensions of 598 x 598 pixels (approx. 540 x 540 µm) at a resolution corresponding to 10X magnification (pixel size approx. 0.90 µm). The process resulted in approximately 5.1 million patches usable for training a DNN. See Appendix for details (Table   S1 ).
Deep neural network model for classification of image patches
We used two DNN ensembles, each consisting of 30 Inception V3 models pre-trained on ImageNet, with classification layers adapted to our outcome. 23, 24 The first ensemble performed binary classification of image patches into benign or malignant, while the second ensemble classified patches into Gleason patterns 3 to 5. To reduce label noise in the latter case, we trained the ensemble on patches extracted from cores containing only one Gleason pattern (i.e. cores with Gleason score 3+3, 4+4, or 5+5). Importantly, the test data still contained cores of all grades to provide a real-world scenario for evaluation. Each DNN in the first and the second ensemble thus predicted the probability of each patch being malignant, and whether it represented Gleason pattern 3, 4, or 5, respectively. See Appendix for details ( Figure S2 ).
Boosted tree model for core-level estimation of cancer grade and length
Once the probabilities for the Gleason pattern at each location of the biopsy core were obtained from the DNN ensembles, we mapped them to core-specific characteristics (ISUP grade and cancer length) using boosted trees. 25 All cores in the training data were used for training the boosted trees. Specifically, aggregated features from the patch-wise probabilities predicted by each DNN for each core were used as input to the boosted trees, and the clinical assessment of ISUP score and cancer length were used as outcomes. See Appendix for details.
Evaluation metrics Cancer detection
We summarized the operating characteristics of the AI system in a Receiver Operating Characteristic (ROC) curve and the Area Under the ROC Curve (AUC). We then specified a range of acceptable sensitivities for potential clinical use, and evaluated achieved specificity (both on core-level and patient-level) when compared to the pathology report.
Cancer length estimation
We predicted cancer length in each core and compared it to the cancer length described in the pathology report. The comparison was undertaken on individual cores as well as on aggregated cores (i.e. total cancer length) for each man. Linear correlation was assessed on both all cores and men, as well as restricted to positive cores and men. In addition, the patch-wise predictions were mapped to their spatial locations on each biopsy core, thus permitting the generation of visualizations of the predictions.
ISUP grading
Cohen's kappa with linear weights was used for evaluating the AI's performance against pathologists on the Imagebase test set. Linear weights emphasize a higher level of disagreement of ratings further away from each other on the ordinal ISUP scale, in accordance with previous publications on the Imagebase study. 19 Each of the 87 slides in
Imagebase was graded by each of the 23 Imagebase panel pathologists, and additionally by the AI. To evaluate how well the AI agreed with the pathologists, we calculated all pair-wise kappas and summarized the average for each of the 23 raters. In addition, we estimated the kappa with a grouping of the Gleason scores in ISUP grades (grade groups) 1, 2-3 and 4-5.
Results

Cancer detection
We estimated the AUC representing the ability of the AI to distinguish malignant from benign cores to 0.997 (Figure 1 ). For predicting whether a man had cancer or not, the AUC was 0.999. As an example (Figure 1 ; second row from top), at a sensitivity of 99.6%, the AI achieved a specificity of 86.6%. At this sensitivity level, the AI failed to detect three cores with cancer (two ISUP grade 1 and one ISUP grade 2, all with less than 0.5 mm cancer) across 721 malignant biopsy cores in the independent test data. No cancer was misdiagnosed since other malignant cores from the same men were correctly classified.
Cancer length estimation
A visualization of the estimated localization of malignant tissue for an example biopsy is presented in Figure 2 . The correlation between the cancer length estimates of the AI and the measurements of the pathologist was 0.96 (0.93 for positive cores). When aggregating the cancer extent of all cores within a case, the correlation was 0.98, both for all men and for men positive for cancer ( Figure  3 ). An online tool (https://tissuumaps.research.it.uu.se/sthlm3/) allows interactive examination of predictions generated for 30 cores randomly selected (5 per ISUP score and 5 benign) from the test set.
ISUP grading
The average pairwise kappa achieved by the AI relative to the panel of pathologists on the The kappa obtained by the AI relative to the pathology report in the independent test set of 1,631 cores was 0.83 for all cores and 0.70 for positive cores only (see Appendix, Figure   S4 ).
Discussion
Grading prostate cancer can be a difficult procedure due to the complex nature of the score and its derivation. This has also been true for computer algorithms aiming at automating grading. The challenge is not only to develop an AI for this task, but also to demonstrate that it is consistent with current state-of-the-art diagnosis of prostate histopathology. Here, we
have for the first time demonstrated AI-based grading of prostate biopsies on the level of leading urological pathologists represented by the ISUP Imagebase panel.
Due to the poor discriminative ability of the prostate specific antigen test and the systematic biopsy protocol of 10-12 needle cores, which is still in common usage, most biopsies encountered in clinical practice are of benign tissue. To reduce the workload of assessing these samples, we evaluated the AI's ability to assist the pathologist by pre-screening benign from malignant cores. With an estimated AUC of 0.997, the system could automatically remove 809 benign biopsies from 246 men without missing a single man out of the 211 with cancer diagnosed by the study pathologist (Figure 1 ). Since the pathology report was used as gold standard for this evaluation, the AI, by design, cannot achieve a higher sensitivity than the reporting pathologist. However, some malignant cores may still be overlooked by the pathologist but detected by the AI. As an illustration of this, Ozkan et al.
evaluated the agreement of two pathologists in the assessment of cancer in biopsy cores. 5 Following examination of 407 cases, one pathologist found cancer in 231 cases, while the other found cancer in 202 cases. This suggests that an AI can not only streamline the workflow but could also improve sensitivity by detecting cancer foci that would otherwise be accidentally overlooked.
In this study, we have also evaluated the assessment of tumor burden (cancer length). We believe that both cancer detection and cancer length measurements can now be automated without sacrificing patient safety. In support of this and to provide interpretations of the DNN's predictions, we have published on our website high-resolution images of 30 cores randomly selected from the test data, accompanied by their ISUP grades and the AI's predictions.
The first attempt to use DNNs for the detection of cancer on prostate biopsies was reported by Litjens et al. 15 Using an approach similar to ours but based on a small dataset, they could The strengths of our study include the use of well-controlled, prospectively collected and population-based data covering a large random sample of men with both the urologists and the pathologist blinded to patient characteristics. Prostate cancers diagnosed in STHLM3 are representative for a screening-by-invitation setting, and the data include cancer variants that are notoriously difficult to diagnose (pseudohyperplastic and atrophic carcinoma), slides which required immunohistochemistry, and mimickers of cancer (Table S6 ). Despite these difficult cases, the AI achieved near perfect diagnostic concordance with the study pathologist. The study was subjected to a strict protocol, where the splitting of cases into training and test sets was performed at a patient level and all analyses were pre-specified prior to the evaluation of the independent test set, including code for producing tables, figures, and result statistics. A further strength is the use of Imagebase which is a unique dataset for testing the performance of the AI against highly experienced urological pathologists.
We trained the AI using annotations from a single, highly experienced urological pathologist (L.E.). The decision to rely on a single pathologist for model training was done to avoid presenting the AI with conflicting labels for the same morphological patterns and to thereby achieve more consistent predictions. L.E. has in several studies demonstrated high concordance with other experienced uro-pathologists, and therefore represents a good reference for model training. 28, 29 For model evaluation, however, it is critical to assess performance against multiple pathologists ( Figure 3 ).
The main limitation of this study is the lack of exact pixel-wise annotations, since the annotations may highlight regions that include a mixture of benign and malignant glands of different grades. To address this issue, we used a patch size large enough to cover glandular structures but small enough to minimize the presence of mixed grades within a patch, and we focused our attention on core and patient level performance metrics, which avoids caveats of patch-level evaluation and is clinically more meaningful.
Conclusions
We have demonstrated that an AI based on DNNs can reach the level of highly experienced urological pathologists for the grading of prostate biopsies. We believe that the use of this system can increase sensitivity and promote patient safety by providing decision-support and by focusing the attention of the pathologist on regions of interest. In addition, the use of this system can reduce high intra-observer variability in the reporting of prostate histopathology by producing reproducible and consistent grading. A further benefit is that AI can provide diagnostic expertise in regions where this is currently unavailable. Our results warrant international validation, which we are pursuing in an ongoing project where we collect slides from seven countries.
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Additional contributions
The Tampere and a randomly selected negative core. Finally, we randomly selected 139 cancer-free men from whom we included one randomly selected core. Table 1 shows the distribution of grades among the selected men.
Due to the relatively few biopsy cores with GS 5+5 in the Stockholm-3 study, we collected an additional set of 271 slides from 93 men with high grade disease. Out of these slides, 23
were graded by Lars Egevad at Karolinska Hospital. The remaining 248 slides were collected in the Capio S:t Göran Hospital (Stockholm) between 2016-2017, and re-graded by Lars Egevad for the purpose of the AI development presented here. As these samples are not part of the Stockholm-3 cohort, we did not include them in the evaluation (i.e. in the independent test set), but only used them in training to improve the AI system's discrimination for high grade disease.
The linear cancer extent was generally measured from end to end in cases with discontinuous cancer. However, in cases with 1 or 2 cores infiltrated by low grade discontinuous cancer with a benign gap exceeding 3 mm, benign tissue was subtracted in the reporting of total cancer extent.
Image acquisition
The first round of slides was digitized using a Hamamatsu C9600-12 scanner and NDP.scan 4. Image pre-processing
Segmentation of tissue
Our image pre-processing workflow is depicted in Figure S1 . First, we employed a Laplacian filtering algorithm to separate tissue from background and pen mark annotations. We first read images downsampled by a factor of 16 directly from the resolution pyramids present in the image files using Openslide . Any remaining pen marks were removed based on their color by performing the HSV transform and excluding any objects whose mean hue was less than 0.7.
The final binary tissue masks T were rescaled back to full resolution using nearest neighbor interpolation, followed by lossless PackBits compression, and storage in Tiff or BigTiff format (depending on image dimensions) using a tile size of 1024 and 'Chunky' planar configuration.
Segmentation of pen marks
To segment the penmark annotations, downsampled images were first read and converted to grayscale as described above for the tissue segmentation. Dark regions were extracted by applying Otsu's thresholding 5 , followed by taking the complement of the resulting binary mask and applying morphological closing with a disk-shaped structuring element having a radius of 50 µm. Candidate pen mark regions were obtained via a pixel-wise logical operation as the set of pixels belonging to the dark regions but not belonging to the tissue regions. The regions were further refined by filling of holes and removal of objects having an area smaller than 100 000 µm 2 or width less than 400 µm. The minimal width criterion is needed to remove the long but thin slide edges visible in some WSIs. Any remaining out-offocus tissue regions falsely detected as pen marks were removed based on their color by performing the HSV transform and excluding any objects, whose mean hue exceeded 0.6.
The final binary pen masks P were rescaled back to full resolution using nearest neighbor interpolation, followed by lossless PackBits compression, and storage in Tiff or BigTiff format (depending on image dimensions) using a tile size of 1024 and 'Chunky' planar configuration.
Digitization of annotations
Relying on the tissue masks T and pen masks P, we generated digital pixel-wise label masks L, indicating whether each pixel represents background, normal tissue or cancer tissue. For this purpose, the tissue and pen masks were utilized at a resolution corresponding to downsampling by a factor of 16 relative to full resolution. A smoothed version of the tissue mask T s was generated by applying morphological closing with a diskshaped structuring element having a radius of 100 µm, followed by filling of holes.
In order to populate a binary mask C indicating tissue pixels labeled as cancerous, each pen mark region P i in pen mask P was processed according to the following algorithm:
1. Smooth P i by morphological closing with a disk-shaped structuring element (radius 100 µm) and fill holes.
2. Set any overlapping tissue and pen mark pixels T s ∩ P i to FALSE in both masks.
3. Find the set of pixels at tissue boundaries T B .
4. Find the set of pixels at the boundaries of this pen mark P B .
5. For each pixel in P B , find nearest pixel in T B via Kd-tree search 6 to construct the set of nearest tissue pixels T N .
6. Discard all pixel pairs in P B and T N located further than 2000 µm from each other. 11. Assign the set of pixels H ∩ T a value of TRUE in C.
Based on the mask C, annotated tissue pixels were assigned the label 2 (i.e. cancer) in the label mask L. Non-annotated tissue pixels located on the same tissue sections as annotated tissue were assigned the label 1 (i.e. normal). Non-tissue regions and tissue regions not containing any annotated tissue were assigned the label 0 (i.e. background/unknown). The slides in our dataset typically contain two tissue sections, only one of which is annotated with pen marks by a pathologist, and we therefore chose to disregard the unannotated section to reduce label uncertainty.
To avoid regions with locally inconsistent labels, we refined the initial label mask L by first applying morphological dilation with a disk-shaped structuring element (radius 100 µm) to the regions labeled as cancer, and then applied the same operation to the regions labeled as normal tissue. Finally, we introduced some margin at the boundaries of cancerous tissue by dilating the regions labeled as cancer with a disk-shaped structuring element (radius 700 µm) and assigning the label 0 (i.e. unknown) to all tissue pixels within the expanded region.
For slides containing only benign tissue and hence no pen marks, we directly assigned the label 1 to all tissue pixels indicated by T instead of applying the algorithm described above.
For a subset of 62 slides with grade-specific annotations relying on color-coded pen marks, we used a modified version of the above algorithm. For each pen mark region P i on these slides, we computed the mean RGB value of the region from the original image. We then The final unsigned 8-bit integer label masks L were rescaled back to full resolution using nearest neighbor interpolation, followed by lossless LZW compression, and storage in Tiff or BigTiff format (depending on image dimensions) using a tile size of 1024 and 'Chunky' planar configuration.
Extracting patches from the WSI
To extract image regions, which are small enough to mainly represent only one class of tissue and to fit in GPU memory, we divided each WSI into smaller, partially overlapping patches. Several preprocessing operations were simultaneously performed: exclusion of non-tissue regions, assignment of class labels for each patch, and adjustment of pixel size.
We used the pre-generated tissue masks T, pen masks P and label masks L as the basis of this process. The masks were downsampled by a factor of 16 via nearest-neighbor interpolation to speed up processing while retaining their original level of fidelity. Patch extraction was run in parallel on multiple CPU cores.
Each WSI was processed following a sliding-window approach with tunable stride s, patch size t and resolution level r. The resolution level corresponds to a downsampling factor of 2 r relative to full resolution and an optical magnification of 20/2 r . We used s = 299 px (approx.
ranging from 598 px (approx. 270 µm) to 1196 px (approx. 540 µm). For each window, we first extracted the corresponding region from T. If less than 50% of the pixels within the region were indicated to be tissue, we skipped to the next window. Otherwise, we extracted the same region from L and assigned the patch a label according to the mode of tissue pixel labels in the label mask. We observed improving classification performance with increasing patch size, up until 1196 px (540 µm), which was the largest size feasible in terms of available GPU memory (data not shown).
We then read the image data of the patch at the specified location and resolution level directly from the resolution pyramids present in the image files using Openslide A total of 10,185 cores were digitized during multiple rounds of scanning (Table S1 ). We developed a database for organizing the images together with clinical information. The filenames of the scanned slides contain the study specific identification variable that is used to link the images to the clinical data. A total of 268 (2.6%) images from scanning had corrupted filenames, which made linkage to clinical data impossible. There was an overlap of slides that were rescanned between rounds of scanning, and in these cases we kept the slides from the first scanning round and excluded 613 rescanned slides. Furthermore, we excluded 45 slides that were duplicated within the same scanning round and 298 slides where there was an inconsistency between the cancer pen mark on the image and the cancer indicator variable in the clinical data.
6. Patch-level classifier 6 .1. Model
We used a two-stage model for classifying individual image patches (see Figure S2 ). The first stage of the model classifies image patches in binary fashion as either benign or cancerous, while the second stage performs Gleason grading. We included the benign class also into the second stage model in order to obtain a richer representation of the data, and to allow optionally applying or evaluating the two model stages separately of each other. The utility of the two-stage approach is three-fold: 1) it allowed us to fully utilize all training data, 2) it allowed uncoupling the training of models for the detection and grading tasks, which require different numbers of training epochs to avoid overfitting, and 3) it enables adjusting the classifier's operating point for the cancer detection task in a straightforward manner, independently of the Gleason grading task (see Section 6.2. for details).
We evaluated the following convolutional neural network (CNN) architectures: Inception V3 8 ,
ResNet50
9 Inception-ResNet V2 10 and Xception
11
. Based on evaluation on validation data (a temporary split of the training data to enable independent evaluation of different models' performance without testing on the independent test set), Inception V3 offered the best performance in terms of classification accuracy (see Section 8.1; Table S2 ). In all cases, we applied global average pooling to the output of the last convolutional layer, followed by a dense layer with softmax activation to output a vector of estimated probabilities over all classes. The input shape was matched to the patch size (typically 598 x 598 pixels).
To improve generalization, we used an ensemble of multiple CNN models at each of the two stages. All these CNNs share the same architecture, and variability within the ensembles arises from the stochastic sampling during training. We used ensembles of 5 CNNs for cross validation experiments on training data and observed improved performance compared to using a single CNN (see Section 8.2.; Table S3 ). When training the final ensembles on all training data, we used 30 CNNs for each of the two stages. Table   S4 -S5).
Training
To improve generalization and to obtain rotational invariance, each patch was randomly rotated by either 0°, 90°, 180° or 270°, and then flipped vertically with a probability of 50% before being fed to the CNN. This data augmentation step was repeated every time a patch was drawn. As a result of this approach, each patch was presented to the CNN in different, randomly sampled orientations at different epochs, without increasing the overall number of patches processed during a single epoch. , and opted for the latter due to faster convergence. We used a minibatch size of 32 for Inception V3, and 16 for all other architectures, as dictated by the amount of available GPU memory.
During training, we employed multiple GPUs following the data parallelism strategy implemented in Keras. More specifically, the model was replicated on each GPU, each minibatch was divided into multiple sub-batches, and each one of them was processed by one GPU. The results were then concatenated on the CPU and the CNN weights were synchronously updated for all model replicas. We typically used two parallel GPUs per training run. Model training took approximately 5 or 3 days per one first stage or second stage CNN, respectively.
Prediction
In the prediction phase, we applied each trained model to all patches from slides representing the test set. No test-time data augmentation was used. This resulted in a set of predicted class-wise probabilities output by each model for each patch. These probabilities were further used as input for slide-level classification (see Section 7).
Visualization
For the purpose of visualization in the online viewer (accessible at https://tissuumaps.research.it.uu.se/sthlm3), we first computed the mean of the predicted probabilities over all the models in the ensemble for each patch, resulting in a single vector of class-wise probabilities per patch. Due to partial overlap between the patches, each pixel in the WSI is covered by multiple patches. Therefore, for each pixel, we computed the mean probabilities over all patches associated with the pixel, resulting in a single vector of classwise probabilities per pixel. Bilinear interpolation was used to scale up the array of probabilities to match the dimensions of the full-resolution WSI.
To represent and store the data as an RGB image, hereafter referred to as a confidence mask, we constructed the channels as follows:
1. Cancer of any grade: The complement of the probability of the benign class predicted by the first stage ensemble. The values were converted from floating point to uint8 precision and the confidence mask was stored in TIFF format using LZW compression. The confidence mask was then tiled into pyramidal DZI format using vips 15 with a tile size of 512, overlap of 16 and PNG compression. The original WSI was tiled similarly to the confidence mask, except for using JPEG compression (quality 80).
7. Slide-level classifier
Model
We employed a model-based approach relying on boosted trees, implemented using The following features were additionally computed for each slide:
-Total number of patches n (1x1) -Number of patches where each class had the highest probability (1 x c)
Training
For training ensembles of boosted trees for cancer detection and cancer length estimation, we used features (see Section 7.1.) computed from the predictions generated for all training slides by the 30 CNNs in the cancer detection ensemble. For cancer detection, we used the binary logistic ('binary:logistic') loss function, a maximum tree depth of 5, and 100 iterations.
For the cancer length estimation, we used the linear regression ('reg:linear') loss function, a maximum tree depth of 2, and 200 iterations.
For training an ensemble of boosted trees for ISUP grading, we used features extracted from the predictions generated for all training slides by the 30 CNNs in the grading ensemble. We used the softmax ('multi:softprob') loss function, a maximum tree depth of 3, and 300
iterations. To handle class imbalance, we applied sample weights, which were inversely proportional to the number of training samples representing each ISUP class.
In order to select the maximum tree depth and the number of trees, which we considered the key parameters for the boosted tree models, we performed a parameter grid search. The 
Prediction
In the slide-level prediction phase, the patch-level predictions generated by the CNN ensembles (see Section 6.3.) were aggregated into slide-level features (see Section 7.1) and provided as input to the trained ensembles of boosted trees (see Section 7.2).
Probability of cancer of any grade being present was computed for each slide as the mean We obtained a final classification outcome for each slide by assigning the slide as benign if the average probability estimated by the cancer detection ensemble was below a chosen threshold corresponding to an operating point of choice. The grading results presented in this study are based on an operating point corresponding to a sensitivity of 99%. For slides with probabilities exceeding the threshold and thus classified as malignant, the ISUP score was assigned based on a Bayesian decision rule. The aim of using this approach instead of a simple argmax-rule, based on the estimated probabilities alone, was to encourage assigning higher rather than lower ISUP scores and to recognize the varying severity of misclassifications on the ordinal ISUP scale. More specifically, we assigned the grade to each slide predicted as malignant such that:
that is, given the input class-wise probabilities x, we choose the grade a that minimizes the conditional risk:
where L(y,a) defines the loss associated with assigning grade a when the true grade is y.
We defined our loss matrix L such that:
that is, underestimating a grade is perceived as twice as costly as overestimating a grade, and the cost increases linearly with the magnitude of the error. It should be noted, that this choice of preferring overestimation of ISUP score over underestimation by a factor of two is arbitrary. We based our decision on considerations of the clinical consequences of underestimation relative to overestimation, and on cross-validation experiments. . For each architecture, we trained an ensemble of 5
CNNs for various numbers of epochs (see Section 6 for details). In this experiment, we used a single CNN ensemble for cancer detection, cancer length estimation and grading. For each architecture and number of epochs, we then trained three ensembles of boosted trees for cancer detection, cancer length estimation and grading, using the patch-level predictions from training slides as input (see Section 7 for details).
We evaluated the performance of each CNN architecture in: 1) cancer detection based on the AUC of discriminating malignant from benign biopsies, 2) cancer length estimation based on the linear correlation coefficient between estimated and reported lengths, and 3) grading based on Cohen's kappa computed between the ISUP grades assigned by the AI and the study pathologist for biopsies indicated as malignant by the pathologist (Table S2 ). The results indicated that out of the evaluated architectures, Inception V3 achieved the best performance in all three tasks.
Model ensembling
We evaluated the value of ensembling multiple CNNs to improve generalization based on a 5-fold patient-level cross validation on training data. For each fold, we used patches from the slides of the training patients in that fold to train an ensemble of 5 Inception V3 models for cancer detection and length estimation (see Section 6 for details). We trained all models for 15 epochs. For each fold, we then trained two ensembles of boosted trees for cancer detection and cancer length estimation, using the patch-level predictions generated by 1-5
CNNs for training slides as input (see Section 7 for details).
The trained patch-and slide-level ensembles were then applied to generate predictions for the validation slides in each fold, and the results were aggregated over all five folds. We evaluated performance as a function of ensemble size in cancer detection based on the AUC of discriminating malignant from benign biopsies, and in cancer length estimation based on the linear correlation coefficient between estimated and reported lengths (see Table S3 ). We observed a trend of increasing AUC and correlation with increasing ensemble size.
Number of epochs
We evaluated the optimal number of training epochs for the first stage ensemble of cancer detection CNNs and the second stage ensemble of cancer grading CNNs, based on a 5-fold patient-level cross validation on training data. For each fold, we used patches from the slides of the training patients in that fold to train two ensembles, each consisting of 5 Inception V3 models (see Section 6 for details). We then trained three ensembles of boosted trees for cancer detection, cancer length estimation and grading, using the patch-level predictions from training slides as input (see Section 7 for details). The trained patch-and slide-level ensembles were then applied to generate predictions for the validation slides in each fold, and the results were aggregated over all five folds. The entire process was repeated using However, based on our observations, drawing conclusions on slide level performance based only on patch-level metrics is not straightforward, mainly due to the considerable amount of noise associated with our pixel-level and patch-level ground truth annotations. We therefore chose to evaluate the performance of the system with a sparse sampling over epochs, but with a focus on the slide-level metrics, which are easy to interpret and relevant in view of the system's potential clinical utility.
We evaluated the effect of the number of epochs on: 1) cancer detection based on the AUC of discriminating malignant from benign biopsies (Table S4) , 2) cancer length estimation based on the linear correlation coefficient between estimated and reported lengths (Table   S4) , and 3) grading based on Cohen's kappa computed between the ISUP grades assigned by the AI and the study pathologist for biopsies indicated as malignant by the pathologist (Table S5) . Based on these results, we selected 15 and 60 as the optimal number of epochs for the first and the second stage CNN ensembles, respectively.
Boosted tree hyperparameter selection
To select hyperparameter values for boosted trees, we performed a grid search over different tree numbers and tree depths (see Section 7) and evaluated them on a 5-fold patient-level cross validation on training data. More specifically, we used the patches from slides corresponding to the training patients of each fold to train an ensemble of 5 Inception V3 models for cancer detection and cancer length estimation, and an ensemble of 5
Inception V3 models for grading (see Section 6 for details). That is, we trained a total of 50
CNNs for this experiment. The cancer detection models were trained for 15 epochs and the grading models for 60 epochs. Figure S1 : Image pre-processing workflow. (A) From left to right: tissue (blue outline) and annotations drawn with a pen (red outline) are segmented from the input WSI and stored as binary masks. The annotations are then digitized by projecting the pen marks onto adjacent tissue, and the result is stored as a label mask indicating benign (grey), cancerous (white) and unknown or background (black) pixels. The unknown label is assigned to non-annotated tissue sections on cancerous slides, such as the one here on the left, and pixels adjacent to cancerous tissue within a specified margin. (B) Each WSI is tiled into partially overlapping image patches, extracted from the regions indicated in the tissue mask, resulting in approximately 1000 patches per WSI. In the process, non-tissue pixels are assigned a constant white value to remove any background and pen mark patterns. Each patch is then assigned a label based on the label mask, and benign and cancerous patches are subsequently used as training data. Patches with the unknown label are only used as input in the prediction phase. Figure S2 : Overview of the artificial intelligence system. The tissue region in the input WSI is split into patches (top). The patches are fed as input to a detection ensemble of 30 DNNs for discriminating between benign and malignant patches (left box; top row), and to a grading ensemble of 30 DNNs for classifying patches into Gleason grades 3, 4 and 5 (right box; top row). In the patchlevel prediction phase (both boxes; middle row), each trained DNN outputs a vector of class-wise probabilities for each input patch. The class-wise probabilities, indicated here with squares where the grayscale intensity corresponds to probability value, are mapped back to the locations of the corresponding patches in the WSI to construct a probability map for each class. The maps are summarized into features, which are used as inputs to train ensembles of boosted trees to predict cancer presence and extent (left box; bottom row) and grade (right box; bottom row) for entire WSIs. In the WSI-level prediction phase, outputs from the 30 boosted trees in each ensemble are averaged, and the final classification of each WSI is assigned to the class associated with the highest average probability. Figure S5: Effect of boosted tree parameters on cancer detection. The AUC for discriminating between benign and malignant biopsies is shown for different numbers of trees and tree depths, estimated using cross-validation on the training data. Figure S6 : Effect of boosted tree parameters on cancer length estimation. The linear correlation coefficient between estimated cancer length and that reported by the study pathologist for each biopsy is shown for different numbers of trees and tree depths, estimated using cross-validation on the training data. Figure S7 : Effect of boosted tree parameters on cancer grading. Cohen's kappa between estimated ISUP scores and those reported by the study pathologist for all malignant biopsies is shown for different numbers of trees and tree depths, estimated using cross-validation on the training data. Table S3 : Effect of ensemble size on cancer detection and length estimation performance. Cancer detection (AUC) and length estimation (Correlation) performance as a function of ensemble size for 1-5 Inception V3 models, estimated using cross-validation on the training data. 
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